low-risk mds & the 'repair mds' clinical trial
Published 1 year ago • 473 plays • Length 1:41:17Download video MP4
Download video MP3
Similar videos
-
1:39:00
low risk mds: consultant haematologist, dr dominic culligan, led this informative session for mds uk
-
2:14
insights into the repair-mds trial: danazol vs vbap in lower-risk mds
-
6:37
low-risk mds updates from ash19
-
18:42
novel treatment strategies in low-risk mds: case study
-
1:22:25
low-risk mds: can we prevent progression?
-
0:56
the promise of luspatercept for the treatment of lower-risk mds
-
1:02:31
understanding qol (quality of life) in high-risk mds & aml
-
2:21
how is lower-risk mds treated?
-
7:46
treatment goals for lower risk mds
-
2:12
improving the treatment of low-risk mds: luspatercept, treatment sequencing & disease classification
-
1:14
real-world treatment patterns of patients with low-risk mds reinitiating esas
-
6:36
mds: low-risk disease treatment options
-
3:31
promising treatment options emerging for higher-risk mds & the value of clinical trials
-
1:20
the current standard of care for patients with lower-risk mds
-
7:51
lower risk mds
-
18:14
novel treatment strategies in low-risk mds: challenges and emerging therapies
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
2:11
new therapeutic options for low-risk mds